keyword
https://read.qxmd.com/read/37763249/topiramate-topamax-evolving-role-in-weight-reduction-management-a-narrative-review
#1
REVIEW
Irza Wajid, Alexis Vega, Katherine Thornhill, Jack Jenkins, Chandler Merriman, Debbie Chandler, Sahar Shekoohi, Elyse M Cornett, Alan D Kaye
Obesity has emerged as a widespread disease with epidemic proportions, necessitating effective management to enhance the overall health outcomes of patients. Medical intervention for weight loss becomes necessary when diet and exercise prove ineffective, and topiramate emerges as a potential treatment option for this global problem. Currently approved as an anti-epileptic and migraine prophylaxis medication, topiramate is frequently utilized as adjunctive therapy for patients with mood and eating disorders, as well as for alcohol use disorders...
August 31, 2023: Life
https://read.qxmd.com/read/37266989/comparison-table-some-drugs-for-migraine-prevention-in-adults
#2
JOURNAL ARTICLE
(no author information available yet)
No abstract text is available yet for this article.
June 12, 2023: Medical Letter on Drugs and Therapeutics
https://read.qxmd.com/read/37266987/drugs-for-migraine
#3
JOURNAL ARTICLE
(no author information available yet)
No abstract text is available yet for this article.
June 12, 2023: Medical Letter on Drugs and Therapeutics
https://read.qxmd.com/read/36176870/unfolding-of-novel-independent-missense-mutations-in-vamp2-and-agrn-and-their-collective-role-in-global-developmental-delay-a-case-report
#4
Negar Heidarpour, Adityabikram Singh, Johnna M Caputo, Raquel Barbieri, Vijay S Pampana, Vasudeva G Kamath, Gurjinder Kaur
Vesicle-associated membrane protein 2 ( VAMP2 ) and Agrin ( AGRN ) are crucial proteins in neurotransmission. VAMP2 is a vesicular protein that facilitates the exocytosis of neurotransmitters. At the same time, AGRN plays a critical role in the maintenance and function of neuromuscular junctions. Mutations in the signaling pathway of VAMP2 and AGRN impair proper signaling between the presynaptic and postsynaptic neurons, and can result in neurodevelopmental conditions known as global developmental delay (GDD)...
August 2022: Curēus
https://read.qxmd.com/read/35760585/topiramate-induced-bilateral-angle-closure-glaucoma-a-case-report
#5
JOURNAL ARTICLE
L Magera, Baxant, P Studený
INTRODUCTION: Topamax (topiramate) is a drug used in the treatment of epilepsy or migraine. Its use may rarely be associated with the occurrence of secondary angle-closure glaucoma due to supraciliary effusion. Although the ocular finding resembles primary angle-closure glaucoma, bilateral infliction should always raise the suspicion that it is drug-induced glaucoma. CASE REPORT: The authors present a case of a 51-year-old patient on Topamax therapy with sudden vertigo, headache and blurred vision...
2022: Ceská a Slovenská Oftalmologie
https://read.qxmd.com/read/35419064/metabolic-effects-of-adding-topiramate-on-aripiprazole-in-bipolar-patients-aged-between-6-18-years-a-randomized-double-blind-placebo-controlled-trial
#6
JOURNAL ARTICLE
Soroor Arman, Mostafa Haghshenas
Background: second-generation antipsychotics (SGAs) are associated with metabolic side effects in child and adolescents. The aim of this study is to evaluate the metabolic effects of adding topiramate on aripiprazole in patients with bipolar disorder (BD) aged between 6 and 18 years. Materials and Methods: A 12-week, double-blind, placebo-controlled, randomized trial was conducted in the child psychiatric units of university hospitals. Forty patients aged between 6 and 18 years with new diagnosis of BD participated in the study...
2022: Journal of Research in Medical Sciences: the Official Journal of Isfahan University of Medical Sciences
https://read.qxmd.com/read/35100235/drugs-for-alcohol-use-disorder
#7
JOURNAL ARTICLE
(no author information available yet)
No abstract text is available yet for this article.
December 13, 2021: Medical Letter on Drugs and Therapeutics
https://read.qxmd.com/read/35093398/urinary-metabolic-disturbances-during-topiramate-use-and-their-reversibility-following-drug-cessation
#8
JOURNAL ARTICLE
Daniel L Pelzman, Eman Kazi, Stephen V Jackman, Michelle J Semins
OBJECTIVE: To understand the metabolic disturbances of stone formers currently taking topiramate and to examine the reversibility of these disturbances with cessation of the medication. MATERIALS AND METHODS: All progress notes written by 5 endourologists from a single academic center were retrospectively reviewed from January 2010 to July 2020 containing the words "topiramate" or "topamax." Inclusion criteria were age > 18 and presence of either a 24-hour urine sample or stone analysis while on topiramate...
January 27, 2022: Urology
https://read.qxmd.com/read/35085204/atogepant-qulipta-for-migraine-prevention
#9
JOURNAL ARTICLE
(no author information available yet)
No abstract text is available yet for this article.
November 1, 2021: Medical Letter on Drugs and Therapeutics
https://read.qxmd.com/read/34550111/fenfluramine-fintepla-for-dravet-syndrome
#10
JOURNAL ARTICLE
(no author information available yet)
No abstract text is available yet for this article.
August 9, 2021: Medical Letter on Drugs and Therapeutics
https://read.qxmd.com/read/33976090/stiripentol-diacomit-for-dravet-syndrome
#11
REVIEW
(no author information available yet)
No abstract text is available yet for this article.
March 22, 2021: Medical Letter on Drugs and Therapeutics
https://read.qxmd.com/read/33842124/acute-topiramate-toxicity-in-a-five-year-old-child
#12
Mohammad Baidoun, Mohamed Elgendy
Topiramate (TOPAMAX®) is an anti-epileptic drug for which acute toxicity is infrequently reported. We present the case report of a five-year-old, otherwise healthy boy who presented to the emergency department (ED) for symptoms of acute encephalopathy. He was lethargic, having slurred speech, hallucinating, intermittently agitated, and had multiple episodes of urinating on himself. Computed tomography (CT) of the head, lumbar puncture, electroencephalography, and magnetic resonance imaging (MRI) were all normal...
March 7, 2021: Curēus
https://read.qxmd.com/read/33650235/topiramate-topamax-for-migraine-prophylaxis
#13
JOURNAL ARTICLE
Bing Li, Paniz Johari, Carolina Camacho Ruiz
No abstract text is available yet for this article.
November 2021: Academic Emergency Medicine
https://read.qxmd.com/read/33604219/long-term-comorbid-neuropsychiatric-sequelae-of-hypoxia-at-birth
#14
Christina Mercogliano, Karuna Poddar
Perinatal hypoxia due to obstetric complications has been known to cause neurodevelopmental impairments in infants and children. The severity of the impairments and recovery depends on the degree of hypoxia. There have been some studies which focuses on understanding the effects of perinatal hypoxia on cognitive and behavioral functioning like attention-deficit/hyperactivity disorder (ADHD), autism spectrum disorder (ASD), learning disorders, or aggression. Although the studies have investigated the effects in children, there are very few studies done to explore perinatal hypoxia, causing any neuropsychiatric outcomes in adults...
January 13, 2021: Curēus
https://read.qxmd.com/read/33434187/drugs-for-migraine
#15
JOURNAL ARTICLE
(no author information available yet)
No abstract text is available yet for this article.
October 5, 2020: Medical Letter on Drugs and Therapeutics
https://read.qxmd.com/read/27883934/the-application-of-half-life-in-clinical-decision-making-comparison-of-the-pharmacokinetics-of-extended-release-topiramate-usl255-and-immediate-release-topiramate
#16
COMPARATIVE STUDY
Barry E Gidal, Annie M Clark, Bob Anders, Frank Gilliam
OBJECTIVE: For extended-release drugs with multi-compartment kinetics, such as topiramate, effective half-life (t1/2eff ) may be a more clinically relevant parameter than elimination half-life (t1/2z ). Using topiramate as a real-life example, the objective was to compare these half-life values for immediate- and extended-release topiramate (TPM-IR and USL255, respectively) to understand how drug pharmacokinetics may impact drug dosing recommendations. METHODS: The t1/2z and t1/2eff for USL255 and TPM-IR were compared using data from a phase I study (N=36) of 200mg USL255 administered once daily (QD) or TPM-IR twice daily (BID); effect of sampling duration on t1/2z was investigated...
January 2017: Epilepsy Research
https://read.qxmd.com/read/27437073/phenotypic-assessment-and-the-discovery-of-topiramate
#17
JOURNAL ARTICLE
Bruce E Maryanoff
The role of phenotypic assessment in drug discovery is discussed, along with the discovery and development of TOPAMAX (topiramate), a billion-dollar molecule for the treatment of epilepsy and migraine.
July 14, 2016: ACS Medicinal Chemistry Letters
https://read.qxmd.com/read/25742345/labeling-changes-for-topiramate-topamax-and-doripenem-doribax
#18
JOURNAL ARTICLE
Diane S Aschenbrenner
No abstract text is available yet for this article.
July 2014: American Journal of Nursing
https://read.qxmd.com/read/25657861/anti-epileptic-prophylaxis-in-traumatic-brain-injury-a-retrospective-analysis-of-patients-undergoing-craniotomy-versus-decompressive-craniectomy
#19
JOURNAL ARTICLE
Vivek Ramakrishnan, Robert Dahlin, Omid Hariri, Syed A Quadri, Saman Farr, Dan Miulli, Javed Siddiqi
BACKGROUND: Seizures account for significant morbidity and mortality early in the course of traumatic brain injury (TBI). Although there is sufficient literature suggesting short-term benefits of antiepileptic drugs (AEDs) in post-TBI patients, there has been no study to suggest a time frame for continuing AEDs in patients who have undergone a decompressive craniectomy for more severe TBI. We examined trends in a level-II trauma center in southern California that may provide guidelines for AED treatment in craniectomy patients...
2015: Surgical Neurology International
https://read.qxmd.com/read/25335382/-electrophysiological-study-of-the-effects-of-topiramate-on-neocortical-neurons-in-rats
#20
JOURNAL ARTICLE
S N Kozhechkin, Iu S Mednikova, L G Kolik
The effect of topiramate (topamax) on the electrical activity of frontal cortical neurons of neoencephalon was studied by microelectrode techniques in rats. Topiramate upon acute intraperitoneal administration and microionophoretic application dose-dependently reduced the frequency of spike activity within 17 - 30 min after injection at a dose of 40 and 80 mg/kg. At the same time, the agent did not change the membrane rest potential, and the magnitude and form of action potentials. Microionophoretically applied topiramate decreased the excitatory response to electroosmotically applied ethanol at "small doses" (ejected current < 50 nA) and enhanced the neuronal depression induced by ethanol at "large doses" (ejected current > 50 nA)...
2014: Eksperimental'naia i Klinicheskaia Farmakologiia
keyword
keyword
16559
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.